Profluent Inks Up To $2.25 Bln Deal With Lilly For Genetic Medicines
28/4 14:55
(RTTNews) - Profluent, an AI-first protein design company, on Tuesday announced a multi-program partnership with Eli Lilly and Company worth up ?to $2.25 billion to develop AI-designed enzymes for genetic medicines....